Ramipril-induced agranulocytosis confirmed by a lymphocyte cytotoxicity test

Am J Med Sci. 2005 Jan;329(1):52-3. doi: 10.1097/00000441-200501000-00010.

Abstract

A 50-year-old man who had chronic renal failure presented with neutropenic fever four days after ramipril was initiated. Agranulocytosis due to other causes was ruled out after a bone marrow aspiration and biopsy examination were performed. A relationship between the drug and the adverse effect was suggested. It was established by a novel lymphocyte cytotoxicity test.

Publication types

  • Case Reports

MeSH terms

  • Agranulocytosis / chemically induced*
  • Agranulocytosis / diagnosis*
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects*
  • Cytotoxicity Tests, Immunologic
  • Humans
  • Lymphocytes / drug effects
  • Male
  • Middle Aged
  • Ramipril / adverse effects*

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Ramipril